Vanda Pharmaceuticals VNDA Income Statements

Conto economico

Quarter End	Mar 2022	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	60,19M	64,39M	65,32M	64,48M	62,5M	46,06M	38,82M	45,27M
Reddito operativo	-7,67M	3,46M	3,91M	6,63M	2M	-2,87M	-6M	-7,09M
Reddito ante imposte	-7,56M	3,79M	5,46M	9,61M	5,53M	2,59M	-120k	-1,66M
Reddito netto	-6,43M	2,57M	3,27M	6,86M	3,25M	1,52M	137k	-2,4M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-7,56M	3,79M	5,46M	9,61M	5,53M	2,59M	-120k	-1,66M
EBITDA	-6,97M	4,15M	4,59M	7,29M	2,67M	-2,27M	-5,42M	-5,94M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	146,02M	165,08M	193,12M	227,19M	248,17M	268,68M	254,38M	192,64M
Reddito operativo	-18,57M	-16,9M	21,74M	22,81M	27,24M	42,17M	6,33M	-13,95M
Reddito ante imposte	-17,91M	-15,43M	25,35M	29,03M	31,66M	42,36M	11,3M	6,34M
Reddito netto	-18,01M	-15,57M	25,21M	115,55M	23,34M	33,15M	6,28M	2,51M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-0.409	-0.346	0.48	2.158	0.425	0.593	0.111	0.044
UTILE OPERATIVO	-17,71M	-15,53M	25,85M	29,03M	31,66M	42,36M	11,3M	6,34M
EBITDA	-6,7M	-13,92M	24,69M	25,7M	30,1M	45,04M	9,06M	-10,94M